Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A review;Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Eine Übersicht

Hautarzt

Volumn 64, Issue 8, 2013, Pages 611-624

  Stander S ^a   Metze, D ^a   Luger, T ^a   Schwarz, T ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Drug reaction; HLA B 5701; Hypersensitivity syndrome; Toxic epidermal necrolysis; Typ IV allergy

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; PHENOBARBITAL;

CYTOMEGALOVIRUS; DRESS SYNDROME; ENZYME DEFICIENCY; EPSTEIN BARR VIRUS; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; PATHOGENESIS; REVIEW;

DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY SYNDROME; HUMANS; MULTIPLE ORGAN FAILURE;

EID: 84884664995     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-013-2615-0     Document Type: Review

References (44)

1. An J, Lee JH, Lee H et al (2012) Drug rash with eosinophilia and systemic symptoms syndrome following cholestatic hepatitis A: a case report. Korean J Hepatol 18:84-88
2. Bocquet H, Bagot M, Roujeau JC (1996) Drug induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms). Semin Cutan Med Surg 15:250-257
3. Halink DA, Marijnissen RM et al (2011) Drug reaction with eosinophilia and systemic symptoms induced by carbamazepine: DRESSed to kill. Gen Hosp Psychiatry 33:412
4. Shiohara T, Inaoka M, Kano Y (2006) Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 55:1-8
5. Shiohara T, Kano Y, Takahashi R et al (2012) Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management. Chem Immunol Allergy 97:122-138
6. Giri PP, Roy S, Bhattyacharya S et al (2011) Dress syndrome with sepsis, acute respiratory distress syndrome and pneumomediastinum. Indian J Dermatol 56:763-765
7. Bauer KA, Brimhall AK, Chang TT (2011) Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with azithromycin in acute Epstein-Barr virus infection. Pediatr Dermatol 28:741-743
8. Shiohara T, Kano Y (2007) A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 33:124-133
9. Kardaun SH, Sidoroff A, Valeyrie-Allanore L et al (2007) Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? Br J Dermatol 156:609-611
10. Walsh S, Diaz-Cano S, Higgins E et al (2013) Drug reaction with eosinophilia and systemic symptoms: Is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. Br J Dermatol 168:391-401
11. Gómez-Zorrilla S, Ferraz AV, Pedrós C et al (2012) Levetiracetam-induced drug reaction with eosinophilia and systemic symptoms syndrome. Ann Pharmacother 46:e20
12. Mockenhaupt M (2009) Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. J Dtsch Dermatol Ges 7:142-160
13. Criado PR, Criado RF, Avancini Jde M et al (2012) Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts. An Bras Dermatol 87:435-449
14. Kong Q, Sang H, Zhang M et al (2012) Rhabdomyolysis associated with roxithromycin hypersensitivity syndrome. Indian J Dermatol Venereol Leprol 78:197-199
15. Müller PA, Amann K, Bröcker EB et al (2012) Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome. Hautarzt 63:223-255
16. Ang CC, Wang YS, Yoosuff EL et al (2010) Retrospective analysis of drug-induced hypersensitivity syndrome: a study of 27 patients. J Am Acad Dermatol 63:219-227
17. Lehmann P, Hartung W, Fleck M (2013) Rhabdomyolysis and creatine kinase elevation. Z Rheumatol 72:236-241
18. Ogawa K, Morito H, Hasegawa A et al (2013) Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS). J Dermatol Sci 69(1):38-43
19. Ganeva M, Gancheva T, Lazarova R et al (2008) Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol 47:853-860
20. Cacoub P, Musette P, Descamps V et al (2011) The DRESS syndrome: a literature review. Am J Med 124:588-597
21. Bensaid B, Rozieres A, Nosbaum A et al (2012) Amikacin-induced drug reaction with eosinophilia and systemic symptoms syndrome: delayed skin test and ELISPOT assay results allow the identification of the culprit drug. J Allergy Clin Immunol 130:1413-1414
22. Kang SY, Kim JY, Kim MY et al (2012) Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms syndrome induced by cilostazol and carbamazepine. J Dermatol 39:723-724
23. Loulergue P, Mir O (2012) Raltegravir-induced DRESS syndrome. Scand J Infect Dis 44:802-803
24. Roujeau JC, Mockenhaupt M, Tahan SR et al (2013) Telaprevir-related dermatitis. JAMA Dermatol 149:152-158
25. Bayonne Kombo ES, Gathse A (2013) Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV. Med Mal Infect 43:134-135
26. Rawlins MD, Thompson JW (1977) Pathogenesis of adverse drug reactions. In: Davies DM (Hrsg) Textbook of adverse drug reactions. Oxford University Press, Oxford, S 10
27. Hausmann O, Schnyder B, Pichler WJ (2012) Etiology and pathogenesis of adverse drug reactions. Chem Immunol Allergy 97:32-46
28. Takahashi R, Kano Y, Yamazaki Y et al (2009) Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 182:8071-8079
29. Camous X, Calbo S, Picard D et al (2012) Drug reaction with eosinophilia and systemic symptoms: an update on pathogenesis. Curr Opin Immunol 24:730-735
30. Bohan KH, Mansuri TF, Wilson NM (2007) Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy 27:1425-1439
31. Tohyama M, Hashimoto K, Yasukawa M et al (2007) Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol 157:934-940
32. Barbaud A, Waton J, Herbeth B et al (2013) Comparison of cytokine gene polymorphism in drug-induced maculopapular eruption, urticaria and drug reaction with eosinophilia and systemic symptoms (DRESS). J Eur Acad Dermatol Venereol [Epub ahead of print]
33. Ostrov DA, Grant BJ, Pompeu YA et al (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci U S A 109:9959-9964
34. Norcross MA, Luo S, Lu L et al (2012) Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. AIDS 26:21-29
35. Saag M, Balu R, Phillips E et al (2008) Study of Hypersensitivity to Abacavir and Pharmacogenetic Evaluation Study Team. High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clin Infect Dis 46:1111-1118
36. Pirmohamed M (2012) Genetics and the potential for predictive tests in adverse drug reactions. Chem Immunol Allergy 97:18-31
37. Profaizer T, Eckels D (2012) HLA alleles and drug hypersensitivity reactions. Int J Immunogenet 39:99-105
38. http://www.pei.de/cln-236/nn-154420/SharedDocs/Downloads/vigilanz/bulletin-zur-arzneimittelsicherheit/2012/2-2012,templateId=raw, property=publicationFile.pdf/2-2012.pdf
39. Neuman MG, Cohen L, Nanau RM et al (2012) Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs. Transl Res 159:397-406
40. Chiu ML, Hu M, Ng MH et al (2012) Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong. Br J Dermatol 167:44-49
41. Phillips EJ, Chung WH, Mockenhaupt M et al (2011) Drug hypersensitivity: pharmacogenetics and clinical syndromes. J Allergy Clin Immunol 127:60-66
42. (o A) (2008) "Quality assurance in the lymphocyte transformation test" - addendum to the LTT publication "Methods and quality assurance in environmental medicine" by the RKI Committee. "Methods and quality assurance in environmental medicine" report by the committee. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 51:1070-1076
43. Descamps V, Ben-Saïd B, Sassolas B et al (2010) Management of drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol 137:703-708
44. Moling O, Tappeiner L, Piccin A et al (2012) Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir - a hypothesis. Med Sci Monit 18:57-62